Nexopamil

DB20629ExperimentalSmall molecule

Nexopamil is a small molecule drug. Nexopamil has a monoisotopic molecular weight of 404.3 Da.

Mechanism: Pharmacologically active on Voltage-dependent calcium channel and 5-hydroxytryptamine receptor 2
Curator reviewed
Formula / weight: C₂₄H₄₀N₂O₃ · 404.595 g/mol (avg)

Resolves to

Compound

Structure

InChIKeySKDZEFVVFACNLS-DEOSSOPVSA-NSMILESCCCCCCN(C)CCC[C@](C#N)(C(C)C)C1=CC(OC)=C(OC)C(OC)=C1

What you can answer from here — as of September 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Nexopamil, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.